Long Term Efficacy of a 2-year MRI Treat-to-target Treatment Strategy on Disease Activity, MRI Inflammation and Physical Function in Rheumatoid Arthritis Patients in Clinical Remission: Five Year Follow-up of the IMAGINE-RA Cohort: Five Year Follow-up of the IMAGINE-RA Cohort

Signe Kaas Møller-Bisgaard; Kim Hørslev-Petersen; Daniel Erik Glinatsi; Bo Ejbjerg; Merete Lund Hetland; Jakob Møllenbach Møller; Robin Christensen; Sabrina Mai Nielsen; Mikael Boesen; Kristian Stengaard-Pedersen; Ole Rintek Madsen; Bente Jensen; Jan Alexander Villadsen; Ellen-Margrethe Hauge; Oliver Hendricks; Hanne Merete Lindegaard; Niels Steen Krogh; Anne Grethe Jurik; Henrik Segelcke Thomsen; Mikkel Østergaard

Long Term Efficacy of a 2-year MRI Treat-to-target Treatment Strategy on Disease Activity, MRI Inflammation and Physical Function in Rheumatoid Arthritis Patients in Clinical Remission: Five Year Follow-up of the IMAGINE-RA Cohort: Five Year Follow-up of the IMAGINE-RA Cohort

Signe Kaas Møller-Bisgaard, Kim Hørslev-Petersen, Daniel Erik Glinatsi, Bo Ejbjerg, Merete Lund Hetland, Jakob Møllenbach Møller, Robin Christensen, Sabrina Mai Nielsen, Mikael Boesen, Kristian Stengaard-Pedersen, Ole Rintek Madsen, Bente Jensen, Jan Alexander Villadsen, Ellen-Margrethe Hauge, Oliver Hendricks, Hanne Merete Lindegaard, Niels Steen Krogh, Anne Grethe Jurik, Henrik Segelcke Thomsen, Mikkel Østergaard

Abstract

Background/Purpose:
Targeting MRI remission in rheumatoid arthritis (RA) patients in clinical remission may improve long term clinical, functional and MRI outcomes. The purpose of the IMAGINE-MORE study was to investigate whether a 2-year MRI treat-to-target (T2T) strategy, based on structured MRI assessments targeting absence of osteitis combined with clinical remission, compared with a conventional clinical T2T strategy targeting clinical remission only, improves disease activity, physical function and suppresses MRI-inflammation over 5 years in RA patients

Original language	English
Publication date	2022
Publication status	Published - 2022
Event	ACR 2022 - Philadelphia Duration: 10 Nov 2022 → 14 Nov 2022

Conference

Conference	ACR 2022
City	Philadelphia
Period	10/11/2022 → 14/11/2022

Fingerprint

Dive into the research topics of 'Long Term Efficacy of a 2-year MRI Treat-to-target Treatment Strategy on Disease Activity, MRI Inflammation and Physical Function in Rheumatoid Arthritis Patients in Clinical Remission: Five Year Follow-up of the IMAGINE-RA Cohort: Five Year Follow-up of the IMAGINE-RA Cohort'. Together they form a unique fingerprint.

Cite this

Møller-Bisgaard, S. K., Hørslev-Petersen, K., Glinatsi, D. E., Ejbjerg, B., Hetland, M. L., Møller, J. M., Christensen, R., Nielsen, S. M., Boesen, M., Stengaard-Pedersen, K., Madsen, O. R., Jensen, B., Villadsen, J. A., Hauge, E.-M., Hendricks, O., Lindegaard, H. M., Krogh, N. S., Jurik, A. G., Thomsen, H. S., & Østergaard, M. (2022). Long Term Efficacy of a 2-year MRI Treat-to-target Treatment Strategy on Disease Activity, MRI Inflammation and Physical Function in Rheumatoid Arthritis Patients in Clinical Remission: Five Year Follow-up of the IMAGINE-RA Cohort: Five Year Follow-up of the IMAGINE-RA Cohort. Arthritis & Reumatology Vol 74, number S9, p. 1758. Abstract from ACR 2022, Philadelphia.

Long Term Efficacy of a 2-year MRI Treat-to-target Treatment Strategy on Disease Activity, MRI Inflammation and Physical Function in Rheumatoid Arthritis Patients in Clinical Remission: Five Year Follow-up of the IMAGINE-RA Cohort: Five Year Follow-up of the IMAGINE-RA Cohort. / Møller-Bisgaard, Signe Kaas; Hørslev-Petersen, Kim; Glinatsi, Daniel Erik et al.
2022. Arthritis & Reumatology Vol 74, number S9, p. 1758 Abstract from ACR 2022, Philadelphia.

Research output: Contribution to conference › Conference abstract for conference › Research › peer-review

Møller-Bisgaard, SK, Hørslev-Petersen, K, Glinatsi, DE, Ejbjerg, B, Hetland, ML , Møller, JM, Christensen, R, Nielsen, SM , Boesen, M, Stengaard-Pedersen, K, Madsen, OR, Jensen, B, Villadsen, JA, Hauge, E-M, Hendricks, O, Lindegaard, HM, Krogh, NS, Jurik, AG, Thomsen, HS & Østergaard, M 2022, 'Long Term Efficacy of a 2-year MRI Treat-to-target Treatment Strategy on Disease Activity, MRI Inflammation and Physical Function in Rheumatoid Arthritis Patients in Clinical Remission: Five Year Follow-up of the IMAGINE-RA Cohort: Five Year Follow-up of the IMAGINE-RA Cohort', ACR 2022, Philadelphia, 10/11/2022 - 14/11/2022 pp. Arthritis & Reumatology Vol 74, number S9, p. 1758.

Møller-Bisgaard SK, Hørslev-Petersen K, Glinatsi DE, Ejbjerg B, Hetland ML , Møller JM et al.. Long Term Efficacy of a 2-year MRI Treat-to-target Treatment Strategy on Disease Activity, MRI Inflammation and Physical Function in Rheumatoid Arthritis Patients in Clinical Remission: Five Year Follow-up of the IMAGINE-RA Cohort: Five Year Follow-up of the IMAGINE-RA Cohort. 2022. Abstract from ACR 2022, Philadelphia.

Møller-Bisgaard, Signe Kaas ; Hørslev-Petersen, Kim ; Glinatsi, Daniel Erik et al. / Long Term Efficacy of a 2-year MRI Treat-to-target Treatment Strategy on Disease Activity, MRI Inflammation and Physical Function in Rheumatoid Arthritis Patients in Clinical Remission: Five Year Follow-up of the IMAGINE-RA Cohort : Five Year Follow-up of the IMAGINE-RA Cohort. Abstract from ACR 2022, Philadelphia.

@conference{6dfdfbf3948f4dfbbd71d4ec9b3bd2a3,

title = "Long Term Efficacy of a 2-year MRI Treat-to-target Treatment Strategy on Disease Activity, MRI Inflammation and Physical Function in Rheumatoid Arthritis Patients in Clinical Remission: Five Year Follow-up of the IMAGINE-RA Cohort: Five Year Follow-up of the IMAGINE-RA Cohort",

abstract = "Background/Purpose: Targeting MRI remission in rheumatoid arthritis (RA) patients in clinical remission may improve long term clinical, functional and MRI outcomes. The purpose of the IMAGINE-MORE study was to investigate whether a 2-year MRI treat-to-target (T2T) strategy, based on structured MRI assessments targeting absence of osteitis combined with clinical remission, compared with a conventional clinical T2T strategy targeting clinical remission only, improves disease activity, physical function and suppresses MRI-inflammation over 5 years in RA patients",

author = "M{\o}ller-Bisgaard, {Signe Kaas} and Kim H{\o}rslev-Petersen and Glinatsi, {Daniel Erik} and Bo Ejbjerg and Hetland, {Merete Lund} and M{\o}ller, {Jakob M{\o}llenbach} and Robin Christensen and Nielsen, {Sabrina Mai} and Mikael Boesen and Kristian Stengaard-Pedersen and Madsen, {Ole Rintek} and Bente Jensen and Villadsen, {Jan Alexander} and Ellen-Margrethe Hauge and Oliver Hendricks and Lindegaard, {Hanne Merete} and Krogh, {Niels Steen} and Jurik, {Anne Grethe} and Thomsen, {Henrik Segelcke} and Mikkel {\O}stergaard",

note = "COPECARE; ACR 2022 ; Conference date: 10-11-2022 Through 14-11-2022",

year = "2022",

language = "English",

pages = "Arthritis & Reumatology Vol 74, number S9, p. 1758",

}

TY - ABST

T1 - Long Term Efficacy of a 2-year MRI Treat-to-target Treatment Strategy on Disease Activity, MRI Inflammation and Physical Function in Rheumatoid Arthritis Patients in Clinical Remission: Five Year Follow-up of the IMAGINE-RA Cohort

T2 - ACR 2022

AU - Møller-Bisgaard, Signe Kaas

AU - Hørslev-Petersen, Kim

AU - Glinatsi, Daniel Erik

AU - Ejbjerg, Bo

AU - Hetland, Merete Lund

AU - Møller, Jakob Møllenbach

AU - Christensen, Robin

AU - Nielsen, Sabrina Mai

AU - Boesen, Mikael

AU - Stengaard-Pedersen, Kristian

AU - Madsen, Ole Rintek

AU - Jensen, Bente

AU - Villadsen, Jan Alexander

AU - Hauge, Ellen-Margrethe

AU - Hendricks, Oliver

AU - Lindegaard, Hanne Merete

AU - Krogh, Niels Steen

AU - Jurik, Anne Grethe

AU - Thomsen, Henrik Segelcke

AU - Østergaard, Mikkel

N1 - COPECARE

PY - 2022

Y1 - 2022

N2 - Background/Purpose: Targeting MRI remission in rheumatoid arthritis (RA) patients in clinical remission may improve long term clinical, functional and MRI outcomes. The purpose of the IMAGINE-MORE study was to investigate whether a 2-year MRI treat-to-target (T2T) strategy, based on structured MRI assessments targeting absence of osteitis combined with clinical remission, compared with a conventional clinical T2T strategy targeting clinical remission only, improves disease activity, physical function and suppresses MRI-inflammation over 5 years in RA patients

AB - Background/Purpose: Targeting MRI remission in rheumatoid arthritis (RA) patients in clinical remission may improve long term clinical, functional and MRI outcomes. The purpose of the IMAGINE-MORE study was to investigate whether a 2-year MRI treat-to-target (T2T) strategy, based on structured MRI assessments targeting absence of osteitis combined with clinical remission, compared with a conventional clinical T2T strategy targeting clinical remission only, improves disease activity, physical function and suppresses MRI-inflammation over 5 years in RA patients

M3 - Conference abstract for conference

SP - Arthritis & Reumatology Vol 74, number S9, p. 1758

Y2 - 10 November 2022 through 14 November 2022

ER -